Acyclovir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Acyclovir
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Acyclovir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

82 API Suppliers, 32 USDMF, 19 CEP/COS, 8 JDMF, 13 EU WC, 36 KDMF, 26 NDC API, 47 Listed Suppliers, $ API Reference Price

82 API Suppliers
32 USDMF
19 CEP/COS
8 JDMF
13 EU WC
36 KDMF
26 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

380 FDF Dossiers, 97 FDA Orange Book, 122 Europe, 17 Canada, 16 Australia, 30 South Africa, 98 Listed Dossiers

380 FDF Dossiers
97 FDA Orange Book
122 Europe
17 Canada
16 Australia
30 South Africa
98 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 200MG/5ML, TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 5%;1%

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 200MG/5ML
TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CREAM;TOPICAL - 5%;1%

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 10 DKSH, 1 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 3 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 22 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 3 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 40 Disintegrants & Superdisintegrants, 39 Direct Compression, 36 Thickeners and Stabilizers, 27 Granulation, 24 Topical, 23 Coating Systems & Additives, 22 Solubilizers, 18 Film Formers & Plasticizers, 17 Lubricants & Glidants, 17 Controlled & Modified Release, 16 Co-Processed Excipients, 13 Parenteral, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 7 Emulsifying Agents, 5 Rheology Modifiers, 3 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin, 1 API Stability Enhancers

71 Fillers, Diluents & Binders
40 Disintegrants & Superdisintegrants
39 Direct Compression
36 Thickeners and Stabilizers
27 Granulation
24 Topical
23 Coating Systems & Additives
22 Solubilizers
18 Film Formers & Plasticizers
17 Lubricants & Glidants
17 Controlled & Modified Release
16 Co-Processed Excipients
13 Parenteral
12 Taste Masking
11 Chewable & Orodispersible Aids
8 Empty Capsules
7 Emulsifying Agents
5 Rheology Modifiers
3 Coloring Agents
2 Surfactant & Foaming Agents
1 Soft Gelatin
1 API Stability Enhancers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 113 Finished Drug Prices

2 US Medicaid Prescriptions
113 Finished Drug Prices

MARKET PLACE

38 APIs, 23 FDF Dossiers

38 APIs
23 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 US Exclusivities, 3 Health Canada Patents

3 US Patents
2 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 12 Others

1 USP
12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 206 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3GlaxoSmithKline Inc.

filter Patent Reset all filters

3 All

01 32098108

filter Product Reset all filters

3 All

01 3Acyclovir

filter Dosage Reset all filters

3 All

01 3Tablet

filter Exp Date Reset all filters

3 All

01 32012-01-29

Inabata Aciclovir

Product Main Page

01

GlaxoSmithKline Inc.

Aciclovir

Fi Europe 2024

Not Confirmed

GlaxoSmithKline Inc.

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-07-03

Brand Name : ZOVIRAX

Patent Number : 2098108

Filing Date : 1992-01-29

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-07-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Aciclovir

Fi Europe 2024

Not Confirmed

GlaxoSmithKline Inc.

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-07-03

Brand Name : ZOVIRAX

Patent Number : 2098108

Filing Date : 1992-01-29

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-07-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Aciclovir

Fi Europe 2024

Not Confirmed

GlaxoSmithKline Inc.

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-29

Date Granted : 2001-07-03

Brand Name : ZOVIRAX

Patent Number : 2098108

Filing Date : 1992-01-29

Strength per Unit : 800 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-29

Date Granted : 2001-07-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?